Immunohistochemical study of neuronal intranuclear and cytoplasmic inclusions in Machado-Joseph disease

Psychiatry and Clinical Neurosciences

Volumn 57, Issue 2, 2003, Pages 205-213

  Hayashi, Masahiro ^a,b   Kobayashi, Katsuji ^b   Furuta, Hisakazu ^a  

^a National Hospital Organization   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

1C2; Cytoplasmic inclusions; Machado Joseph disease; Nuclear inclusions; Ubiquitin

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 1C2; POLYCLONAL ANTIBODY; POLYGLUTAMINE; TRINUCLEOTIDE; UBIQUITIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN NERVE CELL; CELL INCLUSION; CELL NUCLEUS INCLUSION BODY; CHROMOSOME 14; CLINICAL ARTICLE; CONTROLLED STUDY; DENTATE NUCLEUS; DOMINANT INHERITANCE; FEMALE; GENE LOCUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MACHADO JOSEPH DISEASE; MALE; OLIGODENDROGLIA; PONS; SPINAL CORD MOTONEURON; SPINAL CORD VENTRAL HORN; SPINOCEREBELLAR TRACT; SUBSTANTIA NIGRA; TISSUE DISTRIBUTION;

ADULT; AGED; ANTERIOR HORN CELLS; BRAIN; CELL NUCLEUS; CEREBELLAR NUCLEI; CYTOPLASM; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INCLUSION BODIES; MACHADO-JOSEPH DISEASE; MALE; MIDDLE AGED; MOTOR NEURONS; NEURONS; PEPTIDES; PONS; SENSITIVITY AND SPECIFICITY; SPINAL CORD; SPINOCEREBELLAR TRACTS; SUBSTANTIA NIGRA; UBIQUITIN;

EID: 0242432394     PISSN: 13231316     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1819.2003.01102.x     Document Type: Article

References (44)

1. Takiyama Y, Nishizawa M, Tanaka H et al. The gene for Machado - Joseph disease maps to human chromosome 14q. Nat. Genet. 1993; 4: 300-304.
2. Kawaguchi Y, Okamoto T, Taniwaki M et al. CAG expansions in a novel gene for Machado - Joseph disease at chromosome 14q32.1. Nat. Genet. 1994; 8: 221-228.
3. Orr HT, Chung MY, Banfi S et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat. Genet. 1993; 4: 221-226.
4. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosome. Cell 1993; 72: 971-983.
5. Koide R, Ikeuchi T, Onodera O et al. Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat. Genet. 1994; 6: 9-13.
6. Sanpei K, Takano H, Igarashi S et al. Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat. Genet. 1996; 14: 237-238.
7. Zhuchenko O, Bailey J, Bonnen P et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat. Genet. 1997; 15: 62-69.
8. David G, Abbas N, Stevanin G et al. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat. Genet. 1997; 17: 65-70.
9. Takano H, Cancel G, Ikeuchi T et al. Close association between prevalence of dominantly inherited spinocerebellar ataxias with CAG-repeat expansions and frequencies of large normal CAG alleles in Japanese and Caucasian populations. Am. J. Hum. Genet. 1998; 63: 1060-1066.
10. Rosenberg RN. Joseph disease: An autosomal dominant motor system degeneration. In: Duvoisin RC, Plaitakis A (eds). The Olivopontocerebellar Atrophies. Advances in Neurology, Vol. 41. Raven Press, New York, 1978, 179-193.
11. Woods BT, Schaumburg HH. Nigro-spino-dentatal degeneration with nuclear ophthalmoplegia. A unique and partially treatable clinico-pathological entity. J. Neurol. Sci. 1972; 17: 149-166.
12. Rosenberg RN, Nyhan WL, Bay C, Shore P. Autosomal dominant striatonigral degeneration. A clinical, pathologic, and biochemical study of a new genetic disorder. Neurology 1976; 26: 703-714.
13. Romanul FC, Fowler HL, Radvany J, Feldman RG, Feingold M. Azorean disease of the nervous system. N. Engl. J. Med. 1977; 296: 1505-1508.
14. Romanul FC, Radvany J, Fowler HL, Tarsy D. Azorean disease of the nervous system: Report of six additional families. Trans. Am. Neurol. Assoc. 1978; 103: 269-273.
15. Coutinho P, Guimaraes A, Scaravilli F. The pathology of Machado - Joseph disease. Report of a possible homozygous case. Acta Neuropathol. 1982; 58: 48-54.
16. Mizutani T, Oda M, Abe H, Fukuda S, Oikawa H, Kosaka K. Hereditary multisystemic degeneration with unusual combination of cerebellopetal, dentato-rubral, and nigro-subthalamo-pallidal degenerations. Clin. Neuropathol. 1983; 2: 147-155.
17. Iwabuchi K, Kogure T, Oda T et al. Some problem on the clinical phenotype of Machado - Joseph disease in relation between their ages at onset. No Shinkei 1993; 45: 246-254 (in Japanese).
18. Fukutani Y, Matsubara R, Katsukawa K et al. Mild dementia associated with Joseph disease in a Japanese family. Dementia 1993; 3: 38-43.
19. Takei A, Honma S, Kawashima A et al. Beneficial effects of tandospirone on ataxia of a patient with Machado Joseph disease. Psychiatry Clin. Neurosci. 2002; 56: 181-185.
20. Skinner PJ, Koshy BT, Cummings CJ et al. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature 1997; 389: 971-974.
21. DiFiglia M, Sapp E, Chase KO et al. Aggregation of Huntingtin in neuronal intranuclear inclusions and dystrophic neurite in brain. Science 1997; 277: 1990-1993.
22. Paulson HL, Perez MK, Trottier Y et al. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 1997; 19: 333-344.
23. Holmberg M, Duyckaerts C, Durr A et al. Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions. Hum. Mol. Genet. 1998; 7: 913-918.
24. Igarashi S, Koide R, Shimohata T et al. Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nat. Genet. 1998; 18: 111-117.
25. Koyano S, Uchihara T, Fujigasaki H et al. Neuronal intranuclear inclusions in spinocerebellar ataxia type 2: Triple-labeling immunofluorescent study. Neurosci. Lett. 1999; 273: 117-120.
26. Yamada M, Hayashi S, Tsuji S, Takahashi H. Involvement of the cerebral cortex and autonomic ganglia in Machado - Joseph disease. Acta Neuropathol. 2001; 101: 140-144.
27. Fujigasaki H, Uchihara T, Koyano S et al. Ataxin-3 is translocated into the nucleus for the formation of intranuclear inclusions in normal and Machado - Joseph disease brains. Exp. Neurol. 2001; 165: 248-256.
28. Takahashi J, Tanaka J, Arai K et al. Recruitment of nonexpanded polyglutamine proteins to intranuclear aggregates in neuronal intranuclear hyaline inclusion disease. J. Neuropathol. Exp. Neurol. 2001; 60: 369-376.
29. Trottier Y, Lutz Y, Stevanin G et al. Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature 1995; 378:403-406.
30. Fried VA, Smith HT, Hildebrandt E, Weiner K. Ubiquitin has intrinsic proteolytic activity: Implications for cellular regeneration. Proc. Natl Acad. Sci. USA 1987; 84: 3685-3689.
31. Lowe J, Mayer RJ, Landon M, Ubiquitin in neurodegenerative diseases. Brain Pathol. 1993; 3: 55-65.
32. Cummings CJ, Sun Y, Opal P et al. Over-expression of inducible HSP70 chaperon suppresses neuropathology and improves motor function in SCA 1 mice. Hum. Mol. Genet. 2001; 10: 1511-1518.
33. Layfield R, Alban A, Mayer RJ, Lowe J. The ubiquitin protein catabolic disorders. Neuropathol. Appl. Neurobiol. 2001; 27: 171-179.
34. Kalchman MA, Graham RK, Xia G et al. Huntingtin is ubiquitinated and interacts a specific ubiquitin conjugating enzyme. J. Biol. Chem. 1996; 271: 19385-19394.
35. Saudou F, Finkbeiner S, Deuys D, Greenberg ME. Huntington acts in the nucleus to induce apoptosis but death dose not correlate with the formation of intranuclear inclusions. Cell 1998; 95: 55-66.
36. He Y, Delaère P, Duyckaerts C, Wasowicz M, Piette F, Hauw JJ. Two distinctive ubiquitin immunoreactive senile plaques in Alzheimer's disease: Relationship with intellectual status in 29 cases. Acta Neuropathol. 1993; 86: 109-116.
37. Iseki E, Li F, Odawara T, Kosaka K. Hippocampal pathology in diffuse Lewy body disease using ubiquitin immunohistochemistry. J. Neurol. Sci. 1997; 149: 165-169.
38. Salon ML, Morelli L, Castaño EM, Soto EF, Pasquini JM. Defective ubiquitination of cerebral proteins in Alzheimer's disease. J. Neurosci. Res. 2000; 62: 302-310.
39. Yamada M, Piao Y-S, Toyoshima Y, Tsuji S, Takahashi H. Ubiquitinated filamentous inclusions in cerebellar dentate nucleus neurons in dentatorubral-pallidoluysian atrophy contain expanded polyglutamine stretches. Acta Neuropathol. 2000; 99: 615-618.
40. Huynh DP, Del Bibio MR, Ho DH, Pulst SM. Expression of ataxin-2 in brains from normal individuals and patients with Alzheimer's disease and spinocerebellar ataxia 2. Ann. Neurol. 1999; 45: 232-241.
41. Ishikawa K, Fujigasaki H, Saegusa H et al. Abundant expression and cytoplasmic aggregations of [alpha] 1A voltage-dependent calcium channel protein associated with neurodegeneration in spinocerebellar ataxia type 6. Hum. Mol. Genet. 1999; 8: 1185-1193.
42. Perutz MF, Johnson T, Suzuki M, Finch JT. Glutamine repeats as polar zippers: Their possible role in inherited neurodegenerative disease. Proc. Natl Acad. Sci. USA 1994; 91: 5355-5358.
43. Kahlem P, Terre C, Green H, Djian P. Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: Relevance to disease of the nervous system. Proc. Natl Acad. Sci. USA 1996; 93: 14 580-14 585.
44. Sisodia SS. Nuclear inclusions in glutamine repeat disorders: Are they pernicious, coincidental, or beneficial? Cell 1998; 95: 1-4.